insights_auto
Why is ALMKT up 3,36%?
Dive Deeperchevron_right
ALMKT:EPA
Mauna Kea Technologies SA
€0,095
arrow_upward
+3,36%(+0,0031) 1D
13 ພ.ຈ., 10 ໂມງ 43 ນາທີ 11 ວິນາທີ GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALMKT...
Open
€0,09
High
€0,10
Low
€0,09
Mkt. cap
19,64 ລ້ານ
Avg. vol.
541,14 ພັນ
Volume
44,41 ພັນ
P/E ratio
0,81
52-wk high
€0,23
52-wk low
€0,07
EPS
€0,12
Shares outstanding
195,26 ລ້ານ
No. of employees
56
Open
€0,09
High
€0,10
Low
€0,09
Mkt. cap
19,64 ລ້ານ
Avg. vol.
541,14 ພັນ
Volume
44,41 ພັນ
P/E ratio
0,81
52-wk high
€0,23
52-wk low
€0,07
EPS
€0,12
Shares outstanding
195,26 ລ້ານ
No. of employees
56
News stories
From web sources and news partners
MarketWatch
·
48 ນາທີກ່ອນ
Stock Market Today: Dow, S&P 500 and Nasdaq set for flat to weaker start as investors digest Nvidia turmoil, await PPI data: live updates
Benzinga
·
8 ນາທີກ່ອນ
Stock Market Today: Dow Jones, S&P 500 Futures Rise, Nvidia CEO Exit Remains in Focus — CSCO, AMAT, NU in
marketscreener.com
·
4 ຊົ່ວໂມງກ່ອນ
S&P 500 index fell after the Stockholm market closed Thursday
TradingView
·
3 ຊົ່ວໂມງກ່ອນ
SPX: S&P 500 Futures Edge Higher After Nvidia Crisis, 10-Year Yield Hits 5.14%
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA
CEOSacha Loiseau
Employees56
Founded2000
Headquarters-
SectorHealth Care
IndustryMedical device
Websitemaunakeatech.com